The settlement involves McKesson Corp (NYSE:MCK), Cencora Inc (NYSE:COR), and Cardinal Health Inc (NYSE:CAH). The proposed class action settlement, disclosed in a federal court in Cleveland ...

Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

McKesson has jumped 21.7% in 2025 as tariff-shocked investors flee to havens amid the recent stock selloff. At 19 times forward earnings McKesson ...

BofA raised the firm’s price target on McKesson (MCK) to $755 from $665 and keeps a Buy rating on the shares. The recent introduction of ...

By Dietrich Knauth (Reuters) -Washington has reached a $518 million settlement with drug distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc, ending a months-long trial over ...

In a report released today, Daniel Grosslight from Citi maintained a Buy rating on McKesson (MCK – Research Report), with a price target of ...

West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp. Regional pharmacy chain operator Giant Eagle ...

Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and ...